Multinational pharmaceutical company Zydus Cadila has launched Ramelteon Tablets (US RLD —Rozerem Tablets), 8 mg in the US market. The company has already received the final approval from US Federal Drug Administration (USFDA).
Ramelteon is a sedative, also called a hypnotic. It works by affecting certain substances in the body that help regulate the “sleep-wake cycle.” Ramelteon is used to treat insomnia that is associated with having trouble falling asleep. The drug will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad. The group now has 270 approvals and has so far filed over 360 ANDAs since the commencement of the filing process in FY 2003-04.